Adding Corbis Pharma (CRBP) $5.55 to Watch List.
Running Clinical Trials Full Steam With $46 Million Banked in Late February.
Not thinly, but lightly traded. Ready, locked and loaded.
All of the common...
Bill Gates Warns That a Next Pandemic Could Be 10 Times Worse.
Well Alrighty Then. Just as we Were Starting to Get Comfortable Sitting on a Barstool Again..
The Microsoft co-founder explained that humanity is not prepared...
Immuron (IMRN) to Bank $20 Million.
Another Corona Virus Mania Makes Bank. This time $20 million into Immuron which once struggled, when it was trading near $2.00 just last spring.
Adding...
Adding Cyclerion Thera (CYCN) $3.75, to Biotech Stock Review Watch List.
From the Tiki Hut Fund
Cyclerion Therapeutics Inc (CYCN) | And We Have Deal, Up 30%.
LIVE QUOTE
It’s always nice to see a small biotech-startup announce a...
Cybin (CYBN) and Kernel Announce Results from Kernel Flow® Piloting of Feasibility Study Measuring Ketamine’s...
- Preliminary data confirm Flow's ability to successfully measure neuro-effect of ketamine over 10 days -
- Results to be presented at PSYCH Symposium taking...
Provention Bio (PRVB) Updates.
LATEST UPDATE July 13th, 2022, below.
(2021) We're getting way too many calls on this. We'll try to put a blow by blow here. Nothing...
True Nature|Mitesco President & COO, Julie Smith Interview.
Julie R. Smith is a seasoned senior executive and board member with more than 25 years of success spanning healthcare, technology, education and retail....
Revive Therapeutics Gains 25% on Positive FDA Comments.
The Company stated yesterday that it "has received positive comments from the FDA in regard to the Company’s request to determine and agree on...
Psycheceutical Bioscience (BWVI) Secures Funding for Clinical Trials
Psycheceutical Secures Funding for Clinical Trials of NeuroDirect™ Ketamine Topical to Treat PTSD.
Company raises $1.3M USD convertible note from Cantheon Capital for in-human trials...
Op-Ed: Why the US Must Move Beyond Its mRNA Monoculture
BioPharm
David Dodd, GeoVax Labs (NASDAQ: GOVX), opines on why vaccine platform diversity is critical in the United States.
Editor's Note: The views an opinions expressed...
Latest article
Fairchild Gold Corp., Presenting at Palm Beach Investor Roadshow.
Vancouver, British Columbia and Las Vegas, Nevada--(Institutional Analyst - April 8th, 2026) - Fairchild Gold Corp. (TSXV: FAIR) (FSE: Y4Y) (OTCQB: FCHDF) ("Fairchild" or the "Company"),...
Precious Metals Analyst | Mark Reichman | Noble Capital
Mark Reichman
Senior Research Analyst, Industrials and Basic Industries
BIO
Mark joined Noble as a senior research analyst with coverage responsibility in the Industrials and Basic Industries...
